Hydroxychloroquine and azithromycin alter the contractility of living porcine heart slices
The cardiotoxicity risk of hydroxychloroquine (HCQ) and azithromycin (AZM) has been the subject of intensive research triggered by safety concerns in COVID-19 patients. HCQ and AZM have been associated with QT interval prolongation and drug-induced arrhythmias, however other cardiotoxicity mechanism...
Saved in:
Main Authors: | Qin Wu (Author), Abigail J. Ross (Author), Tugce Ipek (Author), Georgina H. Thompson (Author), Robert D. Johnson (Author), Changhao Wu (Author), Patrizia Camelliti (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adjusting the role of hydroxychloroquine with or without azithromycin in patients with COVID-19
by: V. A. Otdelenov, et al.
Published: (2020) -
Hydroxychloroquine, azithromycin and methylprednisolone and in hospital survival in severe COVID-19 pneumonia
by: Ronaldo C. Go, et al.
Published: (2022) -
Effects of cardiac toxicity of combination therapy with hydroxychloroquine and azithromycin in COVID-19 patients
by: Usha Yendrapalli, et al.
Published: (2021) -
Effect of hydroxychloroquine and azithromycin combination use in COVID-19 patients - An umbrella review
by: Kaushik Nag, et al.
Published: (2024) -
Prolonged QT Interval in a Patient With Coronavirus Disease-2019: Beyond Hydroxychloroquine and Azithromycin
by: B K Anupama MBBS, et al.
Published: (2020)